» Authors » Martin Schulz

Martin Schulz

Explore the profile of Martin Schulz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 190
Citations 1759
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int . 2025 Feb; 19(1):1-69. PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
2.
Illyes V, Thanheiser S, Ettlinger F, Schulz M, Haider M
Heliyon . 2024 Dec; 10(8):e29310. PMID: 39669290
Particle-based systems have immense potential for combining thermal energy storage (TES) with renewable energy sources. The so-called sandTES system, which is an active TES system, utilizes sand or other small...
3.
Gu W, de Ledinghen V, Aube C, Krag A, Strassburg C, Castera L, et al.
NEJM Evid . 2024 Oct; 3(11):EVIDoa2400062. PMID: 39437136
Background: Patients with advanced chronic liver disease (ACLD) are at high risk of developing hepatocellular carcinoma (HCC). Therefore, biannual surveillance is recommended. This large-scale multicenter study aimed to stratify the...
4.
Hilgarth H, Gradl G, Metzger N, Dorje F, Schulz M, Wolf C, et al.
Dtsch Arztebl Int . 2024 Oct; 121(16):539-540. PMID: 39411898
No abstract available.
5.
Greene S, Bohm M, Bozkurt B, Butler J, Cleland J, Coats A, et al.
J Card Fail . 2024 Sep; PMID: 39277029
Background: Despite guideline recommendations, many patients with heart failure (HF) do not receive target dosages of renin-angiotensin-aldosterone system inhibitors (RAASis) in clinical practice due, in part, to concerns about hyperkalemia...
6.
Ozbasak H, Elbeheiry H, Schulz M, Rackova L
Gen Physiol Biophys . 2024 Aug; 43(5):469-484. PMID: 39140687
Ruthenium nitrosyl (Ru-NO) complexes are of interest as photoactive nitric oxide (NO) donor candidates for local therapeutic applications. NO plays a crucial regulatory role in skin homeostasis, concentration-dependently affecting processes...
7.
Gotzinger F, Kieble M, Daudi A, Kunz M, Lauder L, Bohm M, et al.
J Hypertens . 2024 Jul; 42(10):1720-1727. PMID: 38973447
Aims: Clinical guidelines support the use of fixed-dose combinations (FDC) for prevention of cardiovascular disease. Implementation of FDC into clinical care remains challenging, and current population-based data are scarce. Methods...
8.
Elbeheiry H, Schulz M
Chemistry . 2024 May; 30(37):e202400709. PMID: 38700927
Based on Boolean logic, molecular keypad locks secure molecular information, typically with an optical output. Here we investigate a rare example of a molecular keypad lock with a chemical output....
9.
Arnet I, Eickhoff C, Sahm L, Caloz S, Mittag M, Schulz M, et al.
Eur J Clin Pharmacol . 2024 Apr; 80(8):1189-1195. PMID: 38647703
Purpose: To propose a paradigm change for the validation procedures of medication adherence questionnaires. Methods: A total of 121 validation procedures of unique questionnaires for medication adherence were analyzed. Results:...
10.
Bhatia S, Le Cam Y, Carrion J, Diamond L, Fennessy P, Gassman S, et al.
Mol Ther Methods Clin Dev . 2024 Mar; 32(2):101220. PMID: 38516694
No abstract available.